Trial Profile
Randomised trial on combined effects of dual blockade of the renin angiotensin system and phosphate binding in diabetic and non-diabetic patients with impaired renal function.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2017
Price :
$35
*
At a glance
- Drugs Enalapril (Primary) ; Irbesartan (Primary) ; Lanthanum carbonate (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms DUAL study
- 03 Aug 2017 New trial record